Your browser doesn't support javascript.
loading
Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab.
Müller, Hermann L; Merks, Johannes H M; Geoerger, Birgit; Grill, Jacques; Hargrave, Darren; Glade Bender, Julia; Gururangan, Sridharan; Navid, Fariba; Johnston, Michael; Bachir, Jeanette; Elze, Markus C; Fürst-Recktenwald, Sabine.
Affiliation
  • Müller HL; Department of Pediatrics and Pediatric Hematology and Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Oldenburg, Germany.
  • Merks JHM; Department of Pediatric Oncology, Emma Children's Hospital-Academic Medical Center (EKZ-AMC), Amsterdam, The Netherlands.
  • Geoerger B; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France.
  • Grill J; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France.
  • Hargrave D; Paediatric Oncology Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
  • Glade Bender J; Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Medical Centre, New York.
  • Gururangan S; Department of Neurosurgery, Preston A. Wells Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, Florida.
  • Navid F; Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, California.
  • Johnston M; Safety Science Lead, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.
  • Bachir J; Pediatric Oncology, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, 4070, Switzerland.
  • Elze MC; Biostatistics, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, 4070, Switzerland.
  • Fürst-Recktenwald S; Pediatric Oncology, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, 4070, Switzerland.
Pediatr Blood Cancer ; 66(2): e27487, 2019 02.
Article de En | MEDLINE | ID: mdl-30378286

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Développement osseux / Bévacizumab / Antinéoplasiques immunologiques / Tumeurs Limites: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Pediatr Blood Cancer Sujet du journal: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Année: 2019 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Développement osseux / Bévacizumab / Antinéoplasiques immunologiques / Tumeurs Limites: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Pediatr Blood Cancer Sujet du journal: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Année: 2019 Type de document: Article Pays d'affiliation: Allemagne